Natixis Advisors, L.P. Cytokinetics Inc Transaction History

Natixis Advisors, L.P.

$53.5 Billion
Q4 2024

A detailed history of Natixis Advisors, L.P. transactions in Cytokinetics Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 33,659 shares of CYTK stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,659

Previous 37,595 10.47%

Holding current value

$1.56 Million

Previous $1.99 Million 20.25%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$46.36 - $58.62 $182,472 - $230,728	-3,936 Reduced 10.47%	33,659 $1.58 Million
Q3 2024 Nov 06, 2024	SELL	$51.22 - $60.16 $504,312 - $592,335	-9,846 Reduced 20.75%	37,595 $1.99 Million
Q2 2024 Aug 01, 2024	SELL	$47.86 - $75.05 $145,255 - $227,776	-3,035 Reduced 6.01%	47,441 $2.57 Million
Q1 2024 Apr 25, 2024	SELL	$63.75 - $108.06 $795,982 - $1.35 Million	-12,486 Reduced 19.83%	50,476 $3.54 Million
Q4 2023 Feb 06, 2024	BUY	$26.88 - $83.49 $514,053 - $1.6 Million	19,124 Added 43.62%	62,962 $5.26 Million
Q3 2023 Nov 13, 2023	SELL	$29.46 - $36.61 $137,430 - $170,785	-4,665 Reduced 9.62%	43,838 $1.29 Million
Q2 2023 Aug 15, 2023	BUY	$32.62 - $40.75 $282,228 - $352,569	8,652 Added 21.71%	48,503 $1.58 Million
Q1 2023 May 11, 2023	BUY	$33.36 - $45.71 $203,629 - $279,013	6,104 Added 18.09%	39,851 $1.4 Million
Q4 2022 Jan 27, 2023	SELL	$35.77 - $51.11 $87,922 - $125,628	-2,458 Reduced 6.79%	33,747 $1.55 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $46,864 - $66,296	1,216 Added 3.48%	36,205 $1.75 Million
Q2 2022 Aug 12, 2022	BUY	$33.93 - $48.92 $428,909 - $618,397	12,641 Added 56.56%	34,989 $1.38 Million
Q1 2022 May 12, 2022	SELL	$29.74 - $46.0 $10,052 - $15,548	-338 Reduced 1.49%	22,348 $823,000
Q4 2021 Feb 08, 2022	BUY	$34.35 - $46.38 $102,019 - $137,748	2,970 Added 15.06%	22,686 $1.03 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $47,777 - $92,101	2,577 Added 15.04%	19,716 $705,000
Q2 2021 Aug 12, 2021	SELL	$19.79 - $26.99 $15,277 - $20,836	-772 Reduced 4.31%	17,139 $339,000
Q1 2021 May 05, 2021	SELL	$18.57 - $25.68 $18,031 - $24,935	-971 Reduced 5.14%	17,911 $416,000
Q4 2020 Feb 12, 2021	BUY	$15.26 - $28.61 $288,139 - $540,214	18,882 New	18,882 $392,000

Others Institutions Holding CYTK

# of Institutions

396

Shares Held

122M

Call Options Held

3.46M

Put Options Held

1.86M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.37B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Cytokinetics Inc Transaction History